We calculate the Galactic Chemical Evolution of Mo and Ru by taking into account the contribution from ν
p-process nucleosynthesis. We estimate yields of p-nuclei such as 92,94Mo and 96,98Ru through the ν
p-process in various supernova progenitors based upon recent models. In particular, the ν
p-process in energetic hypernovae produces a large amount of p-nuclei compared to the yield in ordinary core-collapse SNe. Because of this, the abundances of 92,94Mo and 96,98Ru in the Galaxy are significantly enhanced at [Fe/H] = 0 by the ν
p-process. We find that the ν
p-process in hypernovae is the main contributor to the elemental abundance of 92Mo at low metallicity [Fe/H] < −2. Our theoretical prediction of the elemental abundances in metal-poor stars becomes more consistent with observational data when the ν
p-process in hypernovae is taken into account.
We study the evolution of rapid neutron-capture process (r-process) isotopes in the galaxy. We analyze relative contributions from core-collapse supernovae (CCSNe), neutron star mergers, and collapsars under a range of astrophysical conditions and nuclear input data. Here we show that, although the r-process in each of these sites can lead to a similar (universal) elemental distribution, the detailed isotopic abundances can differ from one site to another. These differences may allow for the identification of which sources contributed to the early evolution of r-process material in the galaxy. Our simulations suggest that the early evolution was dominated by CCSNe and collapsar r-process nucleosynthesis. This conclusion may be testable if the next generation of observatories can deduce isotopic r-process abundances.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.